| 1 |
Milazzo FM, Chaves-Sanjuan A, Minenkova O, Santapaola D, Anastasi AM, Battistuzzi G, Chiapparino C, Rosi A, Merlo Pich E, Albertoni C, Marra E, Luberto L, Viollet C, Spagnoli LG, Riccio A, Rossi A, Santoro MG, Ballabio F, Paissoni C, Camilloni C, Bolognesi M, De Santis R. Spike mutation resilient scFv76 antibody counteracts SARS-CoV-2 lung damage upon aerosol delivery. Mol Ther 2023;31:362-73. [PMID: 36114671 DOI: 10.1016/j.ymthe.2022.09.010] [Reference Citation Analysis]
|
| 2 |
Lei S, Chen X, Wu J, Duan X, Men K. Small molecules in the treatment of COVID-19. Signal Transduct Target Ther 2022;7:387. [PMID: 36464706 DOI: 10.1038/s41392-022-01249-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 3 |
Hassam M, Bashir MA, Shafi S, Zahra NU, Khan K, Jalal K, Siddiqui H, Uddin R. Identification of potent compounds against SARs-CoV-2: An in-silico based drug searching against Mpro. Comput Biol Med 2022;151:106284. [PMID: 36370580 DOI: 10.1016/j.compbiomed.2022.106284] [Reference Citation Analysis]
|
| 4 |
Mantovani A, Morrone MC, Patrono C, Santoro MG, Schiaffino S, Remuzzi G, Bussolati G, Cappuccinelli P, Fitzgerald G, Bacci ML, Melino G, Parisi G, Rappuoli R, Rezza G, Vineis P, On behalf of the Covid-19 Commission of the Accademia Nazionale dei Lincei. Long Covid: where we stand and challenges ahead. Cell Death Differ 2022;29:1891-1900. [DOI: 10.1038/s41418-022-01052-6] [Reference Citation Analysis]
|
| 5 |
Hammad N, Ransy C, Pinson B, Talmasson J, Bréchot C, Bouillaud F, Rossignol J. Antiviral effect of thiazolides relies on mitochondrial mild uncoupling.. [DOI: 10.1101/2022.09.16.508272] [Reference Citation Analysis]
|
| 6 |
Saloni, Kumari D, Ranjan P, Chakraborty T. A computational study of potential therapeutics for COVID-19 invoking conceptual density functional theory. Struct Chem. [DOI: 10.1007/s11224-022-02048-1] [Reference Citation Analysis]
|
| 7 |
Chuang ST, Buchwald P. Broad-Spectrum Small-Molecule Inhibitors of the SARS-CoV-2 Spike-ACE2 Protein-Protein Interaction from a Chemical Space of Privileged Protein Binders. Pharmaceuticals (Basel) 2022;15. [PMID: 36145305 DOI: 10.3390/ph15091084] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 8 |
Piacentini S, Riccio A, Santopolo S, Pauciullo S, Rossi A, Rossignol J, Santoro MG. Nitazoxanide is a potent inhibitor of human seasonal coronaviruses acting at postentry level: effect on viral spike glycoprotein.. [DOI: 10.1101/2022.07.13.499346] [Reference Citation Analysis]
|
| 9 |
Milazzo FM, Chaves-sanjuan A, Minenkova O, Santapaola D, Anastasi AM, Battistuzzi G, Chiapparino C, Rosi A, Pich EM, Albertoni C, Marra E, Luberto L, Viollet C, Spagnoli LG, Riccio A, Rossi A, Santoro MG, Ballabio F, Paissoni C, Camilloni C, Bolognesi M, De Santis R. Spike mutation resilient scFv76 antibody counteracts SARS-CoV-2 lung damage upon aerosol delivery.. [DOI: 10.1101/2022.05.27.493569] [Reference Citation Analysis]
|
| 10 |
Al-Kuraishy HM, Al-Gareeb AI, Elekhnawy E, Batiha GE. Nitazoxanide and COVID-19: A review. Mol Biol Rep 2022;49:11169-76. [PMID: 36094778 DOI: 10.1007/s11033-022-07822-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
|
